Internal Server Error

Synchron - About the company

Synchron is a series D company based in Brooklyn (United States), founded in 2016 by Rahul Sharma. It operates as a Developer of implantable bioelectronics for the treatment of neurological conditions. Synchron has raised $345M in funding from investors like Khosla Ventures, Arch Venture Partners and Double Point Ventures, with a current valuation of $*****. The company has 83 active competitors, including 28 funded and 7 that have exited. Its top competitors include companies like ElectroCore, Neuralink and ONWARD.

Company Details

Developer of implantable bioelectronics for the treatment of neurological conditions. The company offers a motor neuroprosthesis the Stentrode which helps paralyzed patients regain the ability to communicate. Also, provides endovascular neuromodulation minimally invasive device that stimulates brain or nerve activity for the treatment of Parkinson’s disease, epilepsy, depression, and others.
Social
XFacebook
Email ID
*****@synchron.com, *****@synchron.com
Registered Address
Brooklyn, NY
Key Metrics
Founded Year
2016
Location
Brooklyn, United States
Stage
Series D
Total Funding
$345M in 6 rounds
Latest Funding Round
Post Money Valuation
$***** as on Jan 01, 2026
Ranked
Employee Count
130 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Sign up to download Synchron's company profile

Synchron's funding and investors

Synchron has raised a total funding of $345M over 6 rounds. Its first funding round was on Apr 04, 2017. Its latest funding round was a Series D round on Nov 06, 2025 for $*****. 12 investors participated in its latest round. Synchron has 33 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Synchron:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Nov 06, 2025
6779920
Series D
2769768
4791159
1315282
7107937
Dec 15, 2022
7944685
Series C
6786255
2622898
4633346
Dec 26, 2021
8487551
Grant (prize money)
1288621
5250478
4671755
lockAccess funding benchmarks and valuations. Sign up today!

Synchron's founders and board of directors

Founder? Claim Profile
The founders of Synchron is Rahul Sharma. Thomas Oxley is the CEO of Synchron.
Here are the details of Synchron's key team members:

Synchron's employee count trend

Synchron has 130 employees as of Sep 26. Here is Synchron's employee count trend over the years:
Employee count trend for Synchron
lockUncover Synchron's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Synchron's Competitors and alternates

Top competitors of Synchron include ElectroCore, Neuralink and ONWARD. Here is the list of Top 10 competitors of Synchron, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for ElectroCore
ElectroCore
2005, Basking Ridge (United States), Public
Developer of non-invasive vagus nerve stimulation devices
$161M
69/100
2nd
Logo for Neuralink
Neuralink
2016, Fremont (United States), Series E
Provider of implantable brain-computer interfaces
$1.29B
66/100
3rd
Logo for Synchron
Synchron
2016, Brooklyn (United States), Series D
Developer of implantable bioelectronics for the treatment of neurological conditions
$345M
64/100
4th
Logo for ONWARD
ONWARD
2014, Eindhoven (Netherlands), Public
Developer of a therapeutic device for spinal cord injuries
$35M
61/100
5th
Logo for Nalu Medical
Nalu Medical
2014, Carlsbad (United States), Acquired
Developer of a neurostimulation system for managing intractable chronic pain
$231M
61/100
6th
Logo for Paradromics
Paradromics
2015, Austin (United States), Series A
Provider of data streaming brain-computer interfaces
$88.7M
59/100
7th
Logo for CorTec
CorTec
2010, Freiburg im Breisgau (Germany), Series C
Manufacturer of active implantable neurotechnology devices, components, and sub-assemblies
$21.6M
57/100
8th
Logo for Neurovalens
Neurovalens
2013, Belfast (United Kingdom), Series A
Developer of non-invasive neurostimulation products
$26.1M
57/100
9th
Logo for BlueWind Medical
BlueWind Medical
2010, Herzliya (Israel), Series B
Developer of neurostimulation device for the treatment of overactive bladder
$112M
54/100
10th
Logo for SpineX
SpineX
2018, Los Angeles (United States), Seed
Developer of a medical device for neurological conditions
-
53/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Synchron's competitors? Click here to see the top ones

Synchron's Investments and acquisitions

Synchron has a total of 1 investment in ACQUANDAS. Synchron has not made any acquisitions as of now.

Reports related to Synchron

Here is the latest report on Synchron's sector:

News related to Synchron

lockFilter this list
Media has covered Synchron for a total of 5 events in the last 1 year, 1 of them has been about company updates.
•
Synchron's $460m raise brings brain-computerProactive Investors•Nov 10, 2025•Synchron
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Synchron

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford